The FDA accepted Moderna’s flu vaccine mFLUSIVA, a regulatory determination that comes six months after the company refused to assessment the mRNA shot after which rapidly reversed its place. However a suggestion from a Facilities for Illness Management and Prevention advisory committee is essential for payer protection, and that committee has not met all yr as a result of ongoing litigation.
The publish Moderna Will get FDA Approval for mRNA Flu Vaccine, However CDC Enter Nonetheless Unsure appeared first on MedCity Information.
